Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023
Provided By GlobeNewswire
Last update: Sep 28, 2023
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure
SCORED was one of two randomized, double-blind, placebo-controlled Phase 3 cardiovascular outcomes studies that led to FDA approval
Read more at globenewswire.com
